A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.

5543 Background: The purpose of this study is to assess the antitumor activity and toxicity of a induction chemotherapy regimen combining docetaxel (T), cisplatin (C) and capecitabine (X) followed ...